Aliases & Classifications for Cerebral Hemorrhage

MalaCards integrated aliases for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 38 29

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy, cst3-related and hemorrhage, intracerebral, and has symptoms including angina pectoris, back pain and chest pain. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and Copper homeostasis. The drugs Aspirin and Cilostazol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and lung, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 135)
# Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy, cst3-related 32.7 APP CST3 PRNP
2 hemorrhage, intracerebral 32.3 APP CST3
3 hereditary cerebral amyloid angiopathy 30.0 APP CST3
4 brain edema 29.5 IL1B SOD1
5 ischemia 28.6 APP GFAP SOD1
6 creutzfeldt-jakob disease 28.3 CST3 PRNP
7 alzheimer disease 26.9 APP CST3 GFAP IL1B PRNP SOD1
8 cerebral amyloid angiopathy, app-related 12.1
9 eclampsia 11.2
10 cerebral cavernous malformations 10.8
11 thrombocytopenia 1 10.8
12 cerebritis 10.7
13 amyloidosis 10.4
14 binswanger's disease 10.2 APP GFAP
15 vascular dementia 10.1 APP CST3
16 acute vascular insufficiency of intestine 10.1 IL1B SOD1
17 eales disease 10.1 IL1B SOD1
18 gerstmann-straussler disease 10.1 APP PRNP
19 aortic aneurysm, familial abdominal, 1 10.0 CST3 IL1B
20 tonsillitis 10.0 IL1B SOD1
21 pneumoconiosis 10.0 IL1B SOD1
22 aphasia 10.0 APP PRNP
23 endocarditis 9.8
24 dementia 9.8
25 encephalitis 9.8
26 aging 9.7
27 brain injury 9.7
28 thrombosis 9.7
29 choriocarcinoma 9.7
30 dementia, lewy body 9.7 APP PRNP
31 multiple sclerosis 9.6
32 pheochromocytoma 9.6
33 moyamoya disease 1 9.6
34 leukemia 9.6
35 traumatic brain injury 9.6
36 infective endocarditis 9.6
37 nephrosclerosis 9.6
38 purpura 9.6
39 pancreatitis 9.6
40 pneumonia 9.6
41 neuronitis 9.6
42 herpes simplex 9.6
43 hemophilia 9.6
44 herpes simplex encephalitis 9.6
45 aneurysm 9.6
46 dysphagia 9.6
47 encephalopathy 9.6
48 endotheliitis 9.6
49 maple syrup urine disease 9.6 GFAP SOD1
50 prion disease 9.6 APP IL1B PRNP

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

UMLS symptoms related to Cerebral Hemorrhage:


angina pectoris, back pain, chest pain, edema, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.65 APP CST3 GFAP IL1B SOD1
2 homeostasis/metabolism MP:0005376 9.63 APP CST3 GFAP IL1B PRNP SOD1
3 muscle MP:0005369 9.35 APP CST3 GFAP PRNP SOD1
4 nervous system MP:0003631 9.1 APP CST3 GFAP IL1B PRNP SOD1

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 357)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
2
Cilostazol Approved, Investigational Phase 4,Phase 3,Not Applicable 73963-72-1 2754
3
Probucol Approved, Investigational Phase 4 23288-49-5 4912
4
Enoxaparin Approved Phase 4,Phase 3 9005-49-6 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 55985-32-5 4474
6
Dalteparin Approved Phase 4,Phase 2 9005-49-6
7
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 772 46507594
8 Nadroparin Approved, Investigational Phase 4 9041-08-1
9
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 120202-66-6, 113665-84-2 60606
10
Ticlopidine Approved Phase 4,Phase 3,Early Phase 1 55142-85-3 5472
11
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
12
Cisatracurium Approved Phase 4,Not Applicable 96946-41-7
13
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 6691 54678486
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
15
Simvastatin Approved Phase 4,Phase 2,Not Applicable 79902-63-9 54454
16
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
17
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
18
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 453 6251
19
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
20
Ticagrelor Approved Phase 4 274693-27-5 9871419
21
Amlodipine Approved Phase 4 88150-42-9 2162
22
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
23
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
24
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
25
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
26
Ezetimibe Approved Phase 4 163222-33-1 150311
27
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
28
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
29
Succinylcholine Approved Phase 4,Not Applicable 306-40-1 5314
30
Betamethasone Approved, Vet_approved Phase 4,Not Applicable 378-44-9 9782
31
Indapamide Approved Phase 4 26807-65-8 3702
32
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
33
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
34
Losartan Approved Phase 4 114798-26-4 3961
35
Etomidate Approved Phase 4,Not Applicable 33125-97-2 36339 667484
36
Midazolam Approved, Illicit Phase 4,Not Applicable 59467-70-8 4192
37
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
38
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
39
Desflurane Approved Phase 4 57041-67-5 42113
40
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
41
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
42
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
43
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
44
Menadione Approved, Nutraceutical Phase 4,Phase 3,Not Applicable,Early Phase 1 58-27-5 4055
45
Phytonadione Approved, Investigational, Nutraceutical Phase 4,Phase 3,Not Applicable,Early Phase 1 84-80-0 4812 5284607
46 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable
47
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
48
Caffeine Approved, Nutraceutical Phase 4,Phase 1,Phase 2 58-08-2 2519
49
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
50
Butyric Acid Experimental, Investigational Phase 4,Phase 2,Not Applicable 107-92-6 264

Interventional clinical trials:

(show top 50) (show all 470)
# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
4 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
7 ASCEND: A Study of Cardiovascular Events iN Diabetes Unknown status NCT00135226 Phase 4 aspirin;Omega-3-acid Ethyl Esters;Placebo Aspirin;Placebo omega-3-Ethyl Esters
8 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
9 Clopidogrel for Acute Ischaemia of Recent Onset Unknown status NCT02776540 Phase 4 Clopidogrel;Aspirin
10 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
11 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
12 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
13 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
14 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
15 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed NCT00234065 Phase 4 Cilostazol;Aspirin
16 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
17 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
18 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
19 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
20 A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting Completed NCT02330640 Phase 4 ticagrelor;clopidogrel;asprin
21 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
22 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
23 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
24 Continuous Glucose Monitoring and Preterm Infants Completed NCT02583776 Phase 4
25 Study of Heart and Renal Protection Completed NCT00125593 Phase 4 Simvastatin 20 mg;Ezetimibe 10mg;Placebo
26 Danhong Injection in the Treatment of Chronic Stable Angina Completed NCT01681316 Phase 4 Danhong injection;Placebo
27 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
28 Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Recruiting NCT02699645 Phase 4 telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg;Placebo
29 The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Recruiting NCT02870764 Phase 4 Dan-shen extract;Placebo
30 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
31 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Recruiting NCT03417388 Phase 4 High dose potent statin;PCSK9 Inhibitor;ACE-I (lisinopril) or ARB (losartan);Aspirin
32 Danhong Injection in the Treatment of Acute Ischemic Stroke Recruiting NCT01677208 Phase 4 Danhong injection;placebo
33 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
34 Study of Antithrombotic Treatment After Intracerebral Haemorrhage Not yet recruiting NCT03186729 Phase 4 Antithrombotic Agent
35 Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes Not yet recruiting NCT03264352 Phase 4 Allisartan Isoproxil;Amlodipine 5mg;Hydrochlorothiazide 25 mg;Allisartan Isoproxil placebo;Amlodipine placebo;Hydrochlorothiazide placebo
36 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Not yet recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
37 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
38 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
39 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Withdrawn NCT01042574 Phase 4 Clevidipine butyrate
40 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
41 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
42 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
43 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
44 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3
45 Management of Hypotension In the Preterm Infant Unknown status NCT01482559 Phase 3 Dopamine hydrochloride;Dextrose 5%
46 Cilostazol Stroke Prevention Study for Antiplatelet Combination Unknown status NCT01995370 Phase 3 aspirin;clopidogrel;cilostazol
47 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage Completed NCT00127283 Phase 3 eptacog alfa (activated)
48 Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE) Completed NCT00666328 Phase 3 clevidipine
49 A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular Hemorrhage Completed NCT01041950 Phase 2, Phase 3
50 Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial Completed NCT00041938 Phase 3 aspirin;Warfarin

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Genetic tests related to Cerebral Hemorrhage:

# Genetic test Affiliating Genes
1 Cerebral Hemorrhage 29

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

41
Brain, Heart, Lung, Testes, Kidney, Bone, Bone Marrow

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 287)
# Title Authors Year
1
Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. ( 29844891 )
2018
2
Related Factors of Early Mortality in Young Adults with Cerebral Hemorrhage. ( 29915811 )
2018
3
Response by Fouda and Switzer to Letter Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183950 )
2018
4
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility. ( 29017932 )
2018
5
Lethal cerebral hemorrhage after ticagrelor intoxication: a specific antidote is urgently needed. ( 29889575 )
2018
6
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa I^-related pathway in rats. ( 29928110 )
2018
7
Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. ( 29643882 )
2018
8
Cerebral Venous Sinus Thrombosis with Cerebral Hemorrhage Presenting with Status Epilepticus in Early Pregnancy. ( 29739085 )
2018
9
Recurrent Cerebral Hemorrhage in Normal Pregnancy Secondary to Mycotic Pseudoaneurysms Related to Choriocarcinoma. ( 28987845 )
2018
10
Fetal Cerebral Hemorrhage due to X-linked GATA1 gene mutation. ( 29949202 )
2018
11
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). ( 29433151 )
2018
12
Relationship Between Short Term Variability (STV) and Onset of Cerebral Hemorrhage at Ischemia-Reperfusion Load in Fetal Growth Restricted (FGR) Mice. ( 29867536 )
2018
13
Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials. ( 29929173 )
2018
14
Fatal cerebral hemorrhage in a tetraplegic patient due to autonomic dysreflexia triggered by delay in emptying urinary bladder after unsuccessful intermittent catheterization by carer: lessons learned. ( 29563843 )
2018
15
Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation. ( 29928111 )
2018
16
Letter by Chang et al Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183951 )
2018
17
Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. ( 29737222 )
2018
18
A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. ( 29566704 )
2018
19
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. ( 29247070 )
2018
20
Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type. ( 29706885 )
2018
21
Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy. ( 28090058 )
2017
22
Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. ( 28524787 )
2017
23
Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. ( 28342065 )
2017
24
Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: AA Prospective Cohort Study. ( 28969928 )
2017
25
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. ( 28595677 )
2017
26
Response by Werring and Charidimou to Letter Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030477 )
2017
27
Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study. ( 28739344 )
2017
28
Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. ( 28720659 )
2017
29
Cerebral Hemorrhage following Chiropractic Activator Treatment: Case Report and Review of Literature. ( 28884069 )
2017
30
Cerebral hemorrhage as the initial manifestation in patients with systemic cancer. ( 28724319 )
2017
31
Author's Response to Letter to the Editor: Cerebral Hemorrhage Following Chiropractic Activator Treatment-Case Report and Review of the Literature. ( 29034908 )
2017
32
Letter by Tsivgoulis et al Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030473 )
2017
33
Cerebral hemorrhage therapy by targeting VEGF and HGF in a preclinical trial in rats. ( 28339025 )
2017
34
A Systematic Review and Meta-Analysis on the Treatment of Cerebral Hemorrhage with NaoXueShu Oral Liquid. ( 28630871 )
2017
35
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. ( 28356458 )
2017
36
Cumulative meta-analysis of intensive blood-pressure lowering in acute cerebral hemorrhage: Quo vadis? ( 28320125 )
2017
37
Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. ( 28915688 )
2017
38
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies. ( 28605557 )
2017
39
Effects of Acupuncture on mRNA Levels of Apoptotic Factors in Perihematomal Brain Tissue During the Acute Phase of Cerebral Hemorrhage. ( 28357997 )
2017
40
Fatal cerebral hemorrhage associated with acute pancreatitis: A case report. ( 29390292 )
2017
41
Discovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin. ( 28845297 )
2017
42
TGFI^ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type. ( 28557134 )
2017
43
Sjogren's syndrome complicating pancytopenia, cerebral hemorrhage, and damage in nervous system: A case report and literature review. ( 29390256 )
2017
44
Hypertensive Cerebral Hemorrhage in a Patient with Turner Syndrome Caused by Deletion in the Short Arm of the X Chromosome. ( 29275412 )
2017
45
Investigation on Risk Factors of Ventilator-Associated Pneumonia in Acute Cerebral Hemorrhage Patients in Intensive Care Unit. ( 29391844 )
2017
46
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab. ( 28447276 )
2017
47
Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial. ( 28887388 )
2017
48
Letter to the Editor: Cerebral Hemorrhage following Chiropractic Activator Treatment-Case Report and Review of Literature. ( 29027546 )
2017
49
A Case Report of Maternal Cerebral Hemorrhage in Preterm Pregnancy. ( 28599120 )
2017
50
Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage. ( 27375713 )
2016

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.56 APP CST3 GFAP PRNP SOD1
2 11.06 APP PRNP SOD1
3 10.74 APP PRNP
4 10.68 IL1B PRNP SOD1
5 10.62 APP CST3

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 astrocyte projection GO:0097449 8.96 APP GFAP
2 lysosome GO:0005764 8.92 CST3 GFAP IL1B SOD1

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 cellular response to oxidative stress GO:0034599 9.58 CST3 SOD1
2 locomotory behavior GO:0007626 9.58 APP SOD1
3 positive regulation of JNK cascade GO:0046330 9.57 APP IL1B
4 cellular response to drug GO:0035690 9.56 IL1B PRNP
5 response to nutrient levels GO:0031667 9.55 CST3 SOD1
6 learning or memory GO:0007611 9.54 APP PRNP
7 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.52 APP IL1B
8 cellular response to amyloid-beta GO:1904646 9.51 APP PRNP
9 response to axon injury GO:0048678 9.49 CST3 SOD1
10 regulation of multicellular organism growth GO:0040014 9.48 APP SOD1
11 regulation of peptidyl-tyrosine phosphorylation GO:0050730 9.46 APP PRNP
12 response to copper ion GO:0046688 9.43 PRNP SOD1
13 cellular copper ion homeostasis GO:0006878 9.4 APP PRNP
14 response to carbohydrate GO:0009743 9.37 CST3 IL1B
15 negative regulation of long-term synaptic potentiation GO:1900272 9.32 APP PRNP
16 modulation of age-related behavioral decline GO:0090647 9.26 APP PRNP
17 neuron projection maintenance GO:1990535 9.16 APP PRNP
18 embryo implantation GO:0007566 9.13 CST3 IL1B SOD1
19 response to oxidative stress GO:0006979 8.92 APP CST3 PRNP SOD1

Molecular functions related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 amyloid-beta binding GO:0001540 9.16 CST3 PRNP
2 identical protein binding GO:0042802 9.02 APP CST3 GFAP PRNP SOD1
3 copper ion binding GO:0005507 8.96 PRNP SOD1

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....